Dr John T Macdonald Foundation, Department of Human Genetics, John P Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Cancer Res. 2010 Aug 15;70(16):6401-6. doi: 10.1158/0008-5472.CAN-10-1346. Epub 2010 Jul 27.
MicroRNAs (miRNA) are key regulators of many important biological processes from insulin secretion and fat metabolism to cellular proliferation and differentiation. Given the critical role that these small regulatory RNAs play in biology, it is not surprising that the alteration of miRNA expression patterns can have pathogenic consequences. The association between miRNA dysregulation and pathogenesis has been most widely studied in tumorigenesis, and a large number of miRNAs have been identified whose expression levels are changed in various tumor types. Although the role that miRNAs play in the development of metastasis is more poorly defined, recent studies have begun to identify miRNAs that can regulate key steps in the metastatic cascade. This review focuses on two emerging stories, the regulation of the epithelial-to-mesenchymal transition by members of the miR-200 family, and the pleiotropic nature of the metastasis suppressor miR-31.
微小 RNA(miRNA)是许多重要生物学过程的关键调节因子,从胰岛素分泌和脂肪代谢到细胞增殖和分化。鉴于这些小调节 RNA 在生物学中发挥的关键作用,miRNA 表达模式的改变可能具有致病后果也就不足为奇了。miRNA 失调与发病机制之间的关联在肿瘤发生中得到了最广泛的研究,已经确定了大量 miRNA,其表达水平在各种肿瘤类型中发生改变。尽管 miRNA 在转移发展中的作用还不太明确,但最近的研究已经开始鉴定出可以调节转移级联反应中关键步骤的 miRNA。这篇综述主要关注两个新兴的研究方向,miR-200 家族成员对上皮-间充质转化的调节,以及转移抑制因子 miR-31 的多效性。